Login to Your Account


Scientist: Once Popular BACE1 Not the Best Alzheimer's Target

By Nuala Moran
Staff Writer

Wednesday, February 22, 2012
VANCOUVER, British Columbia – The scientist who discovered beta-secretase (BACE1) and has been highly influential in making it one of the most popular drug targets in Alzheimer's disease now has said inhibiting that enzyme "could impair memory."

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription